| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |